Disseminated Intravascular Coagulation (ISTH 2025)
Disseminated Intravascular Coagulation (ISTH 2025): Suspected DIC → Underlying Disorder Present? → DIC Unlikely.
Interactive Decision Tree
Algorithm Steps
- ▶Start
Suspected DIC
Patient with underlying condition and signs of coagulopathy
- ◆Decision
Underlying Disorder Present?
DIC requires an inciting cause
- Sepsis/severe infection
- Trauma/surgery
- Malignancy (especially APL)
- Obstetric complications
- Vascular abnormalities
- Severe toxic/immunologic reactions
- ✓Outcome
DIC Unlikely
Consider alternative diagnoses
- TTP/HUS
- Liver disease
- Primary fibrinolysis
- Heparin effect
- ●Action
Calculate ISTH DIC Score
Sum points from 4 parameters
- Platelet count: >100=0, 50-100=1, <50=2
- D-dimer: Normal=0, Moderate↑=2, Strong↑=3
- Prolonged PT: <3s=0, 3-6s=1, >6s=2
- Fibrinogen: >1.0g/L=0, <1.0g/L=1
- ◆Decision
ISTH DIC Score Result
Interpret total score
- ●Action
Score <5: Non-Overt DIC
May be early or compensated DIC
- Repeat scoring daily
- Treat underlying cause aggressively
- Monitor for progression
- Consider prophylactic anticoagulation if indicated
- ●Action
Serial Monitoring
Repeat DIC score every 12-24 hours
- CBC with platelets
- PT/PTT
- Fibrinogen
- D-dimer
- Clinical reassessment
- ✓Outcome
DIC Resolving
Score decreasing, clinical improvement
- ✓Outcome
DIC Ongoing
Reassess treatment, consider specialist consult
- ⚠Warning
Score ≥5: Overt DIC
Confirmed DIC - initiate treatment
- ●Action
Treat Underlying Cause
Cornerstone of DIC management
- Antibiotics for sepsis
- Surgical debridement if needed
- Delivery for obstetric DIC
- Chemotherapy for APL (with ATRA)
- Supportive care
- ◆Decision
Predominant Phenotype?
Bleeding vs thrombotic manifestations
- ●Action
Bleeding Predominant
Replacement therapy
- Platelets if <20 or <50 with bleeding
- FFP if PT/PTT prolonged with bleeding
- Cryoprecipitate if fibrinogen <1.5 g/L
- Tranexamic acid may be considered
- Avoid heparin typically
- ●Action
Thrombosis Predominant
Consider anticoagulation
- UFH or LMWH if no contraindication
- Lower prophylactic doses typically
- Balance bleeding risk
- Protein C concentrate in severe sepsis (purpura fulminans)
Guideline Source
Updated definition and scoring of disseminated intravascular coagulation in 2025: ISTH SSC Subcommittee on DIC
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Scoring system requires laboratory values that may not be immediately available
- Does not replace clinical judgment for treatment decisions
- Underlying cause treatment is the cornerstone - not addressed in detail
- May need adaptation for specific populations (liver disease, pregnancy)
Applicable Regions
Global: ISTH scoring system is internationally recognized
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Absolute Neutrophil Count (ANC)
Absolute neutrophil count from CBC for neutropenia grading
Compare
AttendMe.ai vs OpenEvidence
See how this pathway workflow compares against OpenEvidence.
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Related Resources
Frequently Asked Questions
What is the Disseminated Intravascular Coagulation (ISTH 2025)?
The Disseminated Intravascular Coagulation (ISTH 2025) is a diagnostic clinical algorithm for Hematology & Oncology. It provides a structured decision tree to guide clinical decision-making, based on Updated definition and scoring of disseminated intravascular coagulation in 2025: ISTH SSC Subcommittee on DIC.
What guideline is the Disseminated Intravascular Coagulation (ISTH 2025) based on?
This algorithm is based on Updated definition and scoring of disseminated intravascular coagulation in 2025: ISTH SSC Subcommittee on DIC (DOI: 10.1016/j.jtha.2025.03.038).
What are the limitations of the Disseminated Intravascular Coagulation (ISTH 2025)?
Known limitations include: Scoring system requires laboratory values that may not be immediately available; Does not replace clinical judgment for treatment decisions; Underlying cause treatment is the cornerstone - not addressed in detail; May need adaptation for specific populations (liver disease, pregnancy). Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Disseminated Intravascular Coagulation (ISTH 2025) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free